Grassley asks FDA for more information about unapproved prescription drugs
WASHINGTON – Sen. Chuck Grassley has asked the Food and Drug Administration for more information about its review of prescription drugs that are currently on the market without an FDA approval. “There are many physicians and pharmacists under the impression that drugs they administer to patients are safe, and approved by the U.S. government,” Grassley […]
Sen. Grassley Asks HHS Secretary to Review Ethics of FDA-Approved Research
WASHINGTON — Sen. Chuck Grassley, Chairman of the Senate Committee on Finance, today urged the Secretary of Health and Human Services to review the ethics and science of human research that was approved by the Food and Drug Administration and conducted without the voluntary consent of its subjects. Grassley made his request as the Food […]
Sen. Grassley comments on Customs Decision to Stop Crackdown on Imported Irescription Drugs
M E M O R A N D U M TO: Reporters and Editors FR: Jill Kozeny, 202/224-1308 for Chairman Grassley RE: Imported Prescription Drugs DA: Thursday, Oct. 5, 2006 Sen. Chuck Grassley, Chairman of the Senate Committee on Finance, issued the comment below regarding the decision of United States Customs and Border Protection to […]
Grassley, Baucus Seek GAO Review of Pension Agency Structure
WASHINGTON – Sen. Chuck Grassley, chairman of the Committee on Finance, and Sen. Max Baucus, ranking member, have asked the Government Accountability Office to review whether the Pension Benefit Guaranty Corporation has adequate resources and is properly structured to handle the largest demands on services in its history. The senators asked for preliminary findings before […]
Response From the Food and Drug Administration to Letter From Sen. Grassley on Compounding of Inhalation Drugs
The Honorable Charles E. Grassley Chairman Committee on Finance United States Senate Washington, D. C. 20510-6200 Dear Senator Grassley: Thank you for your letter dated July 13,2006, to Acting Commissioner Andrew C. von Eschenbach, M.D.? of the Food and Drug Administration (FDA or the Agency) and Administrator Mark McClellan of the Centers for Medicare & […]
Grassley, Baucus Introduce Tax Technical Corrections
WASHINGTON – Today, Sen. Chuck Grassley, Chairman of the Finance Committee, and Sen. Max Baucus, Ranking Member, introduced S.4026, the Tax Technical Corrections Act of 2006. Committee on Ways and Means Chairman Bill Thomas introduced a companion measure to S. 4026 today as H.R. 6264. The legislation contains technical corrections needed with respect to the […]
Grassley Highlights Good News on Medicare Drug Coverage Prices, Availability for 2007
M E M O R A N D U M To: Reporters and Editors Re: Medicare prescription drug plan information for 2007 Da: Friday, Sept. 29, 2006 Today, the Centers for Medicare and Medicaid Services (CMS) announced information on the 2007 Medicare prescription drug plans. The agency reported that 2007 average monthly premiums will remain […]
Grassley Laments Failure to Extend Widely Used Tax Provisions
Floor Statement of Senator Chuck Grassley: Sorry Fate of Tax Extenders in “Trailer” Package Friday, Sept. 29, 2006 Mr. President, We’ve hit the end of the road on trying to pass the trailer bill separately. It is pretty clear we won’t get a bill to the President’s desk before we recess for the upcoming mid-term […]
Grassley, Baucus Introduce Tax Technical Corrections Bill
WASHINGTON – Today, Sen. Chuck Grassley, Chairman of the Finance Committee, and Sen. Max Baucus, Ranking Member, introduced S.4026, the Tax Technical Corrections Act of 2006. Committee on Ways and Means Chairman Bill Thomas introduced a companion measure to S. 4026 today as H.R. 6264. The legislation contains technical corrections needed with respect to the […]
Grassley Remarks at Nursing Home Quality Summit
Remarks of Senator Chuck Grassley Nursing Home Quality Summit at the National Academy of Sciences Friday, September 29, 2006 Thank you for inviting me to be with you as you work to improve nursing home quality. It’s encouraging that so many organizations, public and private, have agreed to take on this important work. I know […]